Cyclacel Pharmaceuticals Inc expected to post a loss of $4.74 a share - Earnings Preview

Bio Green Med Solution

11/05/2024 24:25

* Cyclacel Pharmaceuticals Inc  CYCC.OQ   CYCC.O  is
expected
to show no change in quarterly revenue when it reports 
results on May 14 for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Cyclacel Pharmaceuticals
Inc
is for a loss of $4.74 per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Cyclacel
Pharmaceuticals Inc is $11.00​, above​ its last closing price
of $2.27. ​​​

This summary was machine generated May 10 at 23:25 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)